Castle Biosciences Inc (NAS:CSTL)
$ 24.37 0.63 (2.65%) Market Cap: 672.79 Mil Enterprise Value: 458.63 Mil PE Ratio: 0 PB Ratio: 1.67 GF Score: 79/100

Castle Biosciences, Inc. - Special Call Transcript

Oct 28, 2020 / 08:30PM GMT
Release Date Price: $49.32 (-3.75%)
Operator

Good afternoon, and welcome to Castle Biosciences DecisionDx DiffDx-Melanoma investor webcast and conference call. As a reminder, today's call is being recorded. (Operator Instructions)

I would like to turn the call over to Derek Maetzold, President and CEO. Please go ahead.

Derek J. Maetzold
Castle Biosciences, Inc. - Founder, CEO, President & Director

Thank you, operator. Good afternoon, everyone. Welcome to Castle Biosciences DecisionDx DiffDx-Melanoma investor webcast and conference call.

As most presentations, the following discussion contains forward-looking statements, and our actual results may differ materially from those discussed here. Additional information concerning factors that could cause such a difference can be found in the disclaimer slide included in the presentation and the company's quarterly report on Form 10-Q for the quarter ended June 30, 2020, and the annual report on Form 10-K for the year ended December 31, 2019.

We have a fairly packed agenda this afternoon. I will open up and set the table of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot